Edge Therapeutics, Inc. (29) | Human Resources (12)

Browse by Subcategory

Recent Contracts

Amended and Restated Executive Employment Agreement by and between Frank K. Bedu-Addo and PDS Biotechnology Corporation, effective as of March 14, 2022 (Filed With SEC on March 31, 2022)
PDS Biotechnology Corporation Change of Control Severance Plan effective as of March 14, 2022 (Filed With SEC on March 31, 2022)
Second Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan (Filed With SEC on December 9, 2020)
Consulting Agreement (Michael King) (Filed With SEC on June 24, 2020)
Executive Employment Agreement by and between Gregory Conn, Ph.D. and PDS Biotechnology Corporation, effective as of March 14, 2022 (Filed With SEC on March 31, 2022)
Executive Employment Agreement by and between Matthew Hill and PDS Biotechnology Corporation, effective as of March 14, 2022 (Filed With SEC on March 31, 2022)
Executive Employment Agreement by and between Lauren V. Wood, M.D. and PDS Biotechnology Corporation, effective as of March 14, 2022 (Filed With SEC on March 31, 2022)
Executive Employment Agreement by and between PDS Biotechnology Corporation and Matthew Hill, dated as of October 4, 2021 (Filed With SEC on October 6, 2021)
Amendment to Employment Agreement by and between PDS Biotechnology Corporation and Gregory Conn, Ph.D., effective as of June 17, 2021 (Filed With SEC on June 21, 2021)
Executive Employment Agreement by and between the Company and Seth L. Van Voorhees, Ph.D (Filed With SEC on December 9, 2020)
Form of Employee Stock Option Agreement under the Second Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan (Filed With SEC on December 9, 2020)
Employment Agreement, effective June 1, 2019, by and between PDS Biotechnology Corporation and Gregory Conn (Filed With SEC on August 1, 2019)